Dashboard
Negative results in Sep 26
- PAT(Latest six months) At Rs 2.75 cr has Grown at -67.30%
- NET SALES(Q) At Rs 23.29 cr has Fallen at -23.19%
- PBT LESS OI(Q) At Rs 0.85 cr has Fallen at -85.88%
With ROE of 7.3, it has a Very Expensive valuation with a 4.7 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Stock DNA
Pharmaceuticals & Biotechnology
INR 789 Cr (Micro Cap)
64.00
40
0.00%
-0.02
7.31%
4.76
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Sep-07-2023
Risk Adjusted Returns v/s 
Returns Beta
News

Shree Ganesh Remedies Ltd is Rated Sell
Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Shree Ganesh Remedies Ltd is Rated Sell
Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Shree Ganesh Remedies Ltd is Rated Sell
Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with the most recent and relevant data to assess the company’s prospects.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18-Nov-2026 | Source : BSETranscript of Earnings Conference Call
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
14-Nov-2026 | Source : BSEAudio Recording - Earnings Call held on November 14 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Nov-2026 | Source : BSEIntimation for invitation of Earnings Conference Call
Corporate Actions 
No Upcoming Board Meetings
Shree Ganesh Remedies Ltd has declared 5% dividend, ex-date: 07 Sep 23
No Splits history available
Shree Ganesh Remedies Ltd has announced 1:5 bonus issue, ex-date: 01 Nov 21
Shree Ganesh Remedies Ltd has announced 7:100 rights issue, ex-date: 03 Feb 23
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Chandulal Manubhai Kothia (48.76%)
Gunjan Jayantibhai Dhorajiya (1.7%)
24.07%
Quarterly Results Snapshot (Consolidated) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is -23.19% vs -6.22% in Sep 2025
YoY Growth in quarter ended Sep 2026 is -67.14% vs -22.62% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -9.59% vs 65.90% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -30.24% vs 72.28% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 0.64% vs -13.74% in Mar 2025
YoY Growth in year ended Mar 2026 is -23.02% vs -17.93% in Mar 2025